Jon C Biro
First SEC filing: Nov. 13, 2017 · Latest: Nov. 13, 2017
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 24, 2026 | PPIH | A | 3,144 | · | · | 10,393 Direct | +43.37% | Acquired | (price as of 2026-10-02) |
| June 25, 2025 | PPIH | A | 5,527 | · | · | 7,249 Direct | +320.96% | Acquired | (price as of 2026-10-02) |
| March 10, 2025 | PPIH | A | 1,722 | · | · | 1,722 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 13, 2018 | HHS | M | 8,000 | · | · | 8,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 13, 2018 | HHS | F | 1,948 | $5.29 | $10,305 | 6,052 Direct | -24.35% | Disposed | -13.8% (price as of 2026-10-02) |
| Nov. 13, 2018 | HHS | M | 8,000 | · | · | 16,000 Direct | -33.33% | Disposed | (price as of 2026-10-02) |
| Nov. 13, 2017 | HHS | A | 338,552 | · | · | 338,552 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 13, 2017 | HHS | A | 240,000 | · | · | 240,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 13, 2017 | HHS | A | 338,552 | · | · | 338,552 Direct | · | Acquired | (price as of 2026-10-02) |
| March 4, 2015 | AROC | A | 20,044 | · | · | 31,371 Direct | +176.96% | Acquired | (price as of 2026-10-02) |
| Sept. 22, 2014 | AROC | A | 11,327 | · | · | 11,327 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 15, 2012 | CRWS | A | 7,000 | · | · | 22,000 Direct | +46.67% | Acquired | (price as of 2026-10-02) |
| Aug. 10, 2011 | CRWS | A | 5,000 | · | · | 15,000 Direct | +50.00% | Acquired | (price as of 2026-10-02) |
| Aug. 16, 2010 | CRWS | A | 5,000 | · | · | 10,000 Direct | +100.00% | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 13, 2018 | HHS | Restricted Stock Units | Common Stock | · | · | 8,000 | Disposed |
| Nov. 13, 2017 | HHS | Stock Option (right to buy) | Common Stock | · | Nov. 13, 2027 | 338,552 | Acquired |
| Nov. 13, 2017 | HHS | Restricted Stock Units | Common Stock | · | · | 240,000 | Acquired |
| Nov. 13, 2017 | HHS | Stock Option (right to buy) | Common Stock | $0.53 | Nov. 13, 2027 | 338,552 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2015 | $355,385 | · | $800,006 | · | · | · | $26,781 | $1,182,172 |
| 2014 | $113,077 | · | $499,974 | · | $100,000 | · | $5,151 | $718,202 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.